Quantcast
Last updated on April 16, 2014 at 17:27 EDT

Latest Ribbon symbolism Stories

2014-01-13 08:26:50

To Expand Clinical Trial for Advanced Ovarian Clear Cell Carcinoma ROCKVILLE, Md., Jan. 13, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of diseases, announced today that it has moved to expand its Phase 2 clinical trial for its drug candidate ENMD-2076 in advanced ovarian clear cell carcinoma (OCCC) with the submission of a new drug global clinical trial application with China's Food and Drug...

2014-01-11 23:01:48

The US Supreme court ruled recently that the test patent is no longer valid causing pricing for Genetic testing to plummet. Thousand Oaks, CA (PRWEB) January 11, 2014 BRCA gene is currently the most well known breast cancer (and ovarian cancer) gene. Women with a BRCA1 and/or BRCA2 gene mutation are up to eight times more likely to develop breast malignancy than women without. In other words, the lifetime risk for getting breast cancer is up to 85%. If and when cancer happens, it tends...

2014-01-10 23:22:17

New Quality Seal Expands RadSite’s Quality-Based Mission to Health Plans and Provider Networks Annapolis, MD and Houston, TX (PRWEB) January 10, 2014 RadSite™, a leading accreditation organization promoting quality-based imaging practices, announces that Solis Women’s Health has received the Network Imaging Certification (NIC) Seal of Distinction. The NIC program opens the doors for RadSite certification to health plans, provider networks, and accountable care organizations that...

2014-01-10 23:03:55

CPIC study finds a correlation between biological subtype and survival. Fremont, CA (PRWEB) January 10, 2014 In a recent study, researchers from the Cancer Prevention Institute of California (CPIC) found that the biological subtype of breast cancer diagnosed in adolescent and young adult women directly affects their risk of dying from the disease. “We have known for a long time that women between the ages of 15 and 39 who have breast cancer are less likely to survive than older women...

2014-01-09 12:26:12

Company Representatives will also attend the 32nd Annual J.P. Morgan Healthcare Conference next week in San Francisco WORCESTER, Mass. and TORONTO, Jan. 9, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, PhD, President of the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), will be a keynote speaker at IBC's 16(th) Annual TIDES Conference (www.IBCLifeSciences.com/Tides) to...

2014-01-07 23:03:25

Describes Medicare and Medicaid coverage, promotes screening for most preventable female cancer in the U.S. Belleville, Ill (PRWEB) January 07, 2014 Allsup, a nationwide Social Security Disability Insurance (SSDI) representation company, is raising awareness of the benefits of preventive care during Cervical Cancer Awareness Month in January. Vaccines to prevent human papillomavirus (HPV), which is the main cause of cervical cancer, make it the most preventable female cancer in the United...

2014-01-07 08:30:40

- Agreement to Distribute Oncotype DX(R) in Australia and New Zealand MELBOURNE, Australia, Jan. 7, 2014 /PRNewswire/ -- Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from chemotherapy, following an agreement between Specialised Therapeutics Australia (STA) and Genomic Health, Inc. (NASDAQ: GHDX). STA has struck an agreement to represent the important...

2014-01-06 12:24:30

Studies Show New Methods for Early Diagnosis of Breast Cancer and Prediction of Its Spread in Women's Health Issue of Clinical Chemistry WASHINGTON, Jan. 6, 2014 /PRNewswire-USNewswire/ -- Two new papers in the "Advancing Women's Health" issue of Clinical Chemistry, the journal of AACC, show for the first time that measuring the amount of certain protein fragments and microRNAs in a woman's blood and breast tissue might enable the early diagnosis of breast cancer or prediction of its...

2014-01-06 08:27:53

WORCESTER, Mass. and TORONTO, Jan. 6, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced the database lock for the primary efficacy analysis of its ongoing AE37 breast cancer vaccine trial. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). A previously released positive interim analysis showed a strong trend toward reduced...

2013-12-27 23:00:19

City of Hope physician urges medical community to use culturally-competent strategies to reach and teach Latinas about the disease. Los Angeles, California (PRWEB) December 27, 2013 As Hispanics continue their population surge across the United States, it becomes more and more evident how underserved this community is – whether in business, politics or the media. However, being underserved by the healthcare industry carries higher, often deadly, stakes. In anticipation of February’s...